Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
472
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
Phen’X Technologies has sold a majority stake to Ciclad
Private Equity | Healthcare | Industrial Machinery & Components

Phen’X Technologies has sold a majority stake to Ciclad

The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.

Learn more
CARSO Group has acquired a majority stake in AQCF Group
Private Equity | Business Support Services | Healthcare

CARSO Group has acquired a majority stake in AQCF Group

CARSO Group, a leading provider of testing services, has acquired a majority stake in AQCF Group, a key player in the field of food safety.

Learn more
Innoxa has sold its eye care activity to Biosynex Group
Consumer & Retail | Healthcare

Innoxa has sold its eye care activity to Biosynex Group

The private shareholders of Laboratoires Innoxa have sold the company’s eye care activity to Biosynex Group.

Learn more
“Since its creation, Formulaction has been at the forefront of technical innovation in helping scientists to directly assess key properties of their materials, from early development to final product design or ‘end use properties’.”

Gérard Meunier

Founder, Formulaction

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=FR&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Strategic moves and sector-specific trends

QUARTERLY M&A ACTIVITY: From securing growth capital to finding future partners, Oaklins' Q3 deals reflect strategic navigation in dynamic industry landscapes.

Learn more

Talk to our local specialists

Antoine Lemaire

Partner
Paris, France
Oaklins France

Meet our global industry specialists

Robert Boersma

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Stuart Goodman

Partner
London, United Kingdom
Oaklins Evelyn Partners

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital